FreeTheAI

STAAR Surgical Hires Johnson & Johnson Executive as Business Development VP

NeutralLow impact
STAA$22.38 0.09%

STAAR Surgical Company (NASDAQ:STAA) has named Andrew Pilon as its new Vice President of Business Development. Reporting directly to Chief Executive Officer Warren Foust, Dr. Pilon will work with executive leaders to find new commercial opportunities and broaden the company's range of vision correction products.

Before this appointment, Dr. Pilon worked at Johnson & Johnson Vision for almost six years, leading surgical business growth initiatives. His career also includes executive positions at Bausch + Lomb, clinical work as an optometrist, and research roles in over three dozen FDA clinical trials. Additionally, he has provided strategic guidance to various venture-backed eye care startups.

In this position, Dr. Pilon is tasked with securing new alliances, licensing deals, and technologies, including finding fresh uses for the company's signature Collamer material. Market observers will monitor how these expansion plans affect the growth of the company's core EVO Implantable Collamer Lenses. Following the news, the company's shares were down 1.01% at 22.14 USD.

Key points

  • STAAR Surgical Company (NASDAQ:STAA) has hired Andrew Pilon to lead its business development efforts.
  • Dr. Pilon previously managed surgical vision partnerships and acquisitions during a nearly six-year tenure at Johnson & Johnson.
  • His new role involves finding strategic alliances, licensing opportunities, and new applications for the company's Collamer material.
  • He brings a background as a practicing optometrist, clinical investigator for FDA trials, and advisor to venture-backed firms.
  • Following the announcement, the company's stock fell 1.01% to 22.14 USD.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

Who is the new Vice President of Business Development at STAAR Surgical?

Andrew Pilon, a trained optometrist with extensive experience in corporate development for eye care companies, has taken the role.

What was Andrew Pilon's previous role before joining STAAR Surgical?

He was the Senior Director of Business Development for the Surgical Vision division at Johnson & Johnson, where he worked for almost six years.

What will Andrew Pilon focus on in his new role at STAAR Surgical?

He will identify strategic partnerships, licensing agreements, and potential acquisitions to expand the company's eye care offerings and find new uses for its Collamer material.